Development of a High-Volume and Robust Testing Process for Cardiovascular Assessment Using Quantitative Bottom-Up Proteomics
ACROBiosystems Efforts and Collaborations in Cancer Immunotherapy
Speaking at The Landscape of Cancer Research 2022, Nicholas Abuid, PhD from ACROBiosystems, presented his talk on providing high purity, customizable, and bioactive reagents to support research and translation in cancer immune therapy. Their catalogue ranges in targets for various diseases.
Re-Convolving the Compositional Landscape of Primary and Recurrent Glioblastoma Reveals Prognostic and Targetable Tissue States
Speaking at The Landscape of Cancer Research 2022, Osama Al Dalahmah, PhD from Colombia University, presented his talk on paving the way to new mechanistic and therapeutic discoveries in glioblastoma.
Enabling Biomarker Discovery and Screening With FirePlex® Multiplex Assays
Multiplex assays combine several target analytes in a single reaction volume, allowing multiple biomarkers to be measured simultaneously.
Advances in Food & Beverage Analysis 2022
The second edition of this online symposium will provide industry and academic scientists with the opportunity to hear from experts within the field. Focus will be given to the safety, authenticity and quality of food and beverages as well as the future of food products such as meat substitutes and alternative proteins
Analysis of Non-Blood Body Fluids
The best fluids for mining disease biomarkers are closest to the site of pathology. For example, rather than serum or plasma, urine is a better fluid to in patients with urinary tract diseases, and stool may be a preferred material to examine in a subject with gastrointestinal disease.
Generation and Validation of CHO HCP ELISA
In bioprocessing, it is critical that host cell proteins (HCPs) can be identified, detected and removed so that the efficacy of the drug is not impacted, and custom process-specific HCP ELISA are typically the preferred method for measuring these contaminants.